2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall StreetThe Motley Fool • 11/07/25
Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/06/25
IOVANCE INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Long-Term Iovance, Inc. StockholdersGlobeNewsWire • 10/29/25
IOVANCE (IOVA) ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Iovance Biotherapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 10/08/25
If You'd Invested $1,000 in IOVA 3 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 08/27/25
Iovance's Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced MelanomaGlobeNewsWire • 08/18/25
IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for AmtagviZacks Investment Research • 08/08/25
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/07/25
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025GlobeNewsWire • 08/07/25
This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy?The Motley Fool • 07/29/25